|
Delayed
Japan Exchange
10:30:00 2026-09-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 2,357.50 JPY | +0.86% |
|
-2.76% | +8.52% |
| Sep. 01 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| Jul. 31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,098B 7.11B 6.16B 5.81B 5.27B 9.89B 681B 9.96B 69.4B 26.74B 346B 26.69B 26.1B | P/E 2027 * |
15.1x | P/E 2028 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 897B 5.8B 5.03B 4.75B 4.31B 8.08B 556B 8.14B 56.69B 21.84B 282B 21.8B 21.32B | EV / Sales 2027 * |
1.96x | EV / Sales 2028 * | 1.89x |
| Free-Float |
81.92% | Yield 2027 * |
3.35% | Yield 2028 * | 3.31% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
Tradegate
| ON4 | Real-time | |
|
OTC Markets
| OPHLF | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Deutsche Boerse AG
| ON4 | Delayed |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +0.86% | ||
| 1 week | -2.76% | ||
| Current month | -3.80% | ||
| 1 month | -2.12% | ||
| 3 months | +4.08% | ||
| 6 months | +0.75% | ||
| Current year | +8.52% |
| 1 week | 2,290.5 |  | 2,430 |
| 1 month | 2,290.5 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.86% | -2.76% | +35.26% | -19.74% | 7.1B | |
| -1.13% | -2.90% | +13.82% | +60.87% | 46.21B | |
| +1.33% | -3.26% | +34.69% | +105.82% | 38.78B | |
| +0.12% | -3.27% | +7.12% | +74.89% | 11.68B | |
| -0.53% | -2.08% | -13.25% | +10.72% | 11.55B | |
| +0.96% | +0.19% | +19.32% | +148.82% | 9.14B | |
| +0.24% | -1.18% | +23.38% | +35.93% | 7.3B | |
| +0.17% | -1.33% | +13.44% | +179.55% | 7.15B | |
| +0.60% | -3.42% | -44.55% | +12.16% | 4.97B | |
| +0.38% | +0.56% | +37.00% | +97.06% | 4.62B | |
| Average | +0.30% | -1.83% | +12.62% | +70.61% | 14.85B | |
| Weighted average by Cap. | +0.12% | -2.96% | +17.22% | +75.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.97B 2.57B 2.43B 2.2B 4.13B 284B 4.16B 28.97B 11.16B 144B 11.14B 10.89B | 448B 2.9B 2.51B 2.37B 2.15B 4.04B 278B 4.07B 28.33B 10.92B 141B 10.9B 10.66B |
| Net income | 72.89B 472M 409M 386M 350M 656M 45.19B 661M 4.61B 1.77B 22.93B 1.77B 1.73B | 63.15B 409M 354M 334M 303M 569M 39.16B 573M 3.99B 1.54B 19.86B 1.53B 1.5B |
| Net Debt | -201B -1.3B -1.13B -1.06B -965M -1.81B -125B -1.82B -12.7B -4.9B -63.25B -4.89B -4.78B | -250B -1.62B -1.4B -1.32B -1.2B -2.25B -155B -2.26B -15.78B -6.08B -78.54B -6.07B -5.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | ¥2,357.50 | +0.86% | 219,600 |
| 26-09-14 | ¥2,337.50 | +0.75% | 1,240,400 |
| 26-09-11 | ¥2,320.00 | -1.00% | 1,647,400 |
| 26-09-10 | ¥2,343.50 | -0.40% | 1,150,900 |
| 26-09-09 | ¥2,353.00 | -2.95% | 1,354,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
